Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany mydrg.de

library_books

Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany

• B.S.
• Montag, 28.04.2008

Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany (Springerlink).

Arzneimittel - Arzneimittel-Resistenz - Kosten-Nutzen - Kostenvergleich - MRSA - Outcome - Verweildauer - URL

« DRG für Beginner | Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany | Waldklinikum Gera nach Privatisierung: Wird Kaufvertrag eingehalten? »